ArrowMark Colorado Holdings’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.9M Sell
775,369
-65,897
-8% -$1.49M 0.42% 72
2025
Q4
$19.9M Buy
841,266
+489,866
+139% +$11.9M 0.44% 66
2025
Q3
$8.75M Buy
+351,400
New +$7.56M 0.16% 149
2022
Q1
Sell
-2,716,826
Closed -$70.3M 352
2021
Q4
$70.3M Buy
2,716,826
+2,455,509
+940% +$61.2M 0.56% 53
2021
Q3
$6.16M Sell
261,317
-4,568
-2% -$159K 0.05% 246
2021
Q2
$11.8M Buy
+265,885
New +$9.81M 0.09% 190

Other funds holding PRVA

ArrowMark Colorado Holdings's PRVA Position: Q1 2026 in Review

ArrowMark Colorado Holdings reduced its Privia Health (PRVA) stake by 7.8% in Q1 2026, selling an estimated $1.49M and leaving 775,369 shares worth $15.9M. The position accounts for 0.42% of the portfolio, ranked #72.

ArrowMark Colorado Holdings first reported a position in PRVA in Q2 2021 and has held it in 6 quarters since. The position peaked at $70.3M in Q4 2021. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • ArrowMark Colorado Holdings held 775,369 shares of Privia Health worth $15.9M as of Q1 2026.
  • ArrowMark Colorado Holdings sold 65,897 Privia Health shares in Q1 2026, an estimated $1.49M.
  • Privia Health made up 0.42% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #72 holding.
  • ArrowMark Colorado Holdings first reported a position in Privia Health in Q2 2021 and has held it in 6 quarters since.
  • ArrowMark Colorado Holdings's Privia Health position peaked at $70.3M in Q4 2021.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.